Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource rightarrow Recombinant Protein rightarrow NOG  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
separator
ELISA Kit ELISA Kit
CLIA Kit CLIA Kit
PCR Kit PCR Kit
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
siRNA siRNA
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
separator
Our Best Sellers moreseparator
separator
 • NCOA4 Antibody
 • Tubulin gamma (TUBG1) Antibody
 • Vascular Endothelial Cell Growth Factor B (VEGF-B) ELISA Kit
 • Apelin 12 (AP12) ELISA Kit
 • Angiopoietin Like Protein 4 (ANGPTL4) ELISA Kit
 • Small Cell Carcinoma (SCC) ELISA Kit
 • Ataxin 1 (ATXN1) ELISA Kit
 • Arylalkylamine N-Acetyltransferase (AA-NAT) ELISA Kit
 • B7-H3 Gene ELISA Kit
 • Phospho Protein Kinase C (P-PKC) ELISA Kit
 • Anthrax Protective Antigen IgG (APA IgG) ELISA Kit
 • Forkhead Box Protein D3 (FOXD3) ELISA Kit
 • Mannan Binding Lectin Associated Serine Protease (MASP) ELISA Kit
 • Free Prostate Specific Antigen (FPSA) ELISA Kit
 downarrow more ...
separator
separator
DatasheetFull DatasheetPrinter Friendly DatasheetPrint This DatasheetAdd to Compare ListHave Questions? Ask UsRequest for a Quotation today

NOG recombinant protein :: Noggin Recombinant Protein

Scan QR to view Datasheet Catalog #    MBS635934 NOG recombinant protein
Unit / Price
0.005 mg  /  $280 +1 FREE 8GB USB
0.02 mg  /  $355 +1 FREE 8GB USB
 
 Go to:   rightarrow  Product Names   rightarrow Product Info   rightarrow Accession #s   rightarrow Product Desc   rightarrow Diseases/Tissues/Pathways   rightarrow Applications   rightarrow References 
 Product Name   

Noggin, Recombinant Protein

 Also Known As   

Noggin, Recombinant, Human

 Product Gene Name   

NOG recombinant protein

[Similar Products]
 Research Use Only    For Research Use Only. Not for use in diagnostic procedures.
Table BarTOPTable Bar
 Chromosome Location    Chromosome: 17; NC_000017.10 (54671060..54672951). Location: 17q22
 OMIM    184460
 3D Structure    ModBase 3D Structure for Q13253
Section Bar
 Host    Recombinant, Human (E Coli)
Section Bar
 Purity/Purification    Molecular Biology Grade
95% by SDS-PAGE gel and HPLC analyse. Endotoxin: 0.1ng/ug (1EU/ug)
 Form/Format    Supplied as a lyophilized powder with no additives. Reconstitute with 10mM Acetic acid to 0.1-1mg/ml. This solution can then be diluted into other aqueous buffers and stored in working aliquots at -20 degree C. NOTE: Due to solubility reasons the protein
Section Bar
Section Bar
 Preparation and Storage    Lyophilized powder may be stored at 4 degree C for short-term only. Reconstitute to nominal volume by adding 10mM Acetic acid, aliquot and store at -20 degree C. Reconstituted product is stable for 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
 Other Notes    Small volumes of NOG recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Table BarTOPTable Bar
 

Product Description specifically for NOG recombinant protein

   Noggin belongs to a group of structurally diverse diffusible proteins which bind TGF-beta ligands and inhibit their access to membrane receptors. This natural antagonist displays high binding-affinity for BMP-2 and -4 and a lower affinity for BMP-7 (OP-1). This protein is secreted as a disulfide-linked homodimer, however the non-disulfide-linked also assume dimeric structure and displays similar biological activity. Recombinant human NOGGIN is a 23.1kD non-disulfide-linked homodimer consisting of 206 amino acid residues.
 Product Categories/Family for NOG recombinant protein    Molecular Biology; MB-Disease Markers
NCBI/Uniprot data below describe general gene information for NOG. It may not necessarily be applicable to this product.
 NCBI GI #    4885523
 NCBI GeneID    9241
 NCBI Accession #    NP_005441.1 [Other Products]
 NCBI GenBank Nucleotide #    NM_005450.4 [Other Products]
Section Bar
 UniProt Primary Accession #    Q13253 [Other Products]
 UniProt Related Accession #    Q13253 [Other Products]
 Molecular Weight    46.2kD [Similar Products]
Table BarTOPTable Bar
 NCBI Official Full Name    noggin
 NCBI Official Synonym Full Names    noggin
 NCBI Official Symbol    NOG [Similar Products]
 NCBI Official Synonym Symbols   
SYM1; SYNS1
[Similar Products]
 NCBI Protein Information    noggin; symphalangism 1 (proximal)
 UniProt Protein Name    Noggin
 Protein Family    Noggin
 UniProt Gene Name    NOG [Similar Products]
 UniProt Entry Name    NOGG_HUMAN
Section Bar
 NCBI Summary for NOG    The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients. The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene. All of these mutations altered evolutionarily conserved amino acid residues. The amino acid sequence of this human gene is highly homologous to that of Xenopus, rat and mouse. [provided by RefSeq, Jul 2008]
Section Bar
 UniProt Comments for NOG    NOG: Essential for cartilage morphogenesis and joint formation. Inhibitor of bone morphogenetic proteins (BMP) signaling which is required for growth and patterning of the neural tube and somite. Defects in NOG are a cause of symphalangism proximal syndrome (SYM1). SYM1 is characterized by the hereditary absence of the proximal interphalangeal (PIP) joints (Cushing symphalangism). Severity of PIP joint involvement diminishes towards the radial side. Distal interphalangeal joints are less frequently involved and metacarpophalangeal joints are rarely affected whereas carpal bone malformation and fusion are common. In the lower extremities, tarsal bone coalition is common. Conducive hearing loss is seen and is due to fusion of the stapes to the petrous part of the temporal bone. Defects in NOG are the cause of multiple synostoses syndrome type 1 (SYNS1); also known as synostoses, multiple, with brachydactyly/symphalangism-brachydactyly syndrome. SYNS1 is characterized by tubular-shaped (hemicylindrical) nose with lack of alar flare, otosclerotic deafness, and multiple progressive joint fusions commencing in the hand. The joint fusions are progressive, commencing in the fifth proximal interphalangeal joint in early childhood (or at birth in some individuals) and progressing in an ulnar-to-radial and proximal- to-distal direction. With increasing age, ankylosis of other joints, including the cervical vertebrae, hips, and humeroradial joints, develop. Defects in NOG are the cause of tarsal-carpal coalition syndrome (TCC). TCC is an autosomal dominant disorder characterized by fusion of the carpals, tarsals and phalanges, short first metacarpals causing brachydactyly, and humeroradial fusion. TCC is allelic to SYM1, and different mutations in NOG can result in either TCC or SYM1 in different families. Defects in NOG are a cause of stapes ankylosis with broad thumb and toes (SABTS); also known as Teunissen- Cremers syndrome. SABTS is a congenital autosomal dominant disorder that includes hyperopia, a hemicylindrical nose, broad thumbs, great toes, and other minor skeletal anomalies but lacked carpal and tarsal fusion and symphalangism. Defects in NOG are the cause of brachydactyly type B2 (BDB2). BDB2 is a subtype of brachydactyly characterized by hypoplasia/aplasia of distal phalanges in combination with distal symphalangism, fusion of carpal/tarsal bones, and partial cutaneous syndactyly. Belongs to the noggin family.

Protein type: Secreted, signal peptide; Secreted

Chromosomal Location of Human Ortholog: 17q22

Cellular Component: extracellular space; extracellular region

Molecular Function: protein binding; protein homodimerization activity; cytokine binding

Biological Process: limb development; wound healing; somatic stem cell maintenance; embryonic skeletal development; motor axon guidance; middle ear morphogenesis; negative regulation of transcription from RNA polymerase II promoter; negative regulation of BMP signaling pathway; BMP signaling pathway; notochord morphogenesis; cell differentiation in hindbrain; negative regulation of cardiac muscle cell proliferation; axial mesoderm development; negative regulation of osteoblast differentiation; skeletal development; negative regulation of cell migration; nervous system development; in utero embryonic development; neural plate morphogenesis; osteoblast differentiation; dorsal/ventral pattern formation; mesoderm formation; endoderm formation; pituitary gland development; spinal cord development; cartilage development; neural tube closure; negative regulation of astrocyte differentiation; epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; embryonic digit morphogenesis; positive regulation of epithelial cell proliferation

Disease: Stapes Ankylosis With Broad Thumb And Toes; Symphalangism, Proximal, 1a; Brachydactyly, Type B2; Tarsal-carpal Coalition Syndrome; Multiple Synostoses Syndrome 1
Table BarTOPTable Bar
 Research Articles on NOG    1. Mutations in the NOG gene are commonly found in congenital stapes ankylosis with symphalangism, but not in otosclerosis.
Table BarTOPTable Bar
 Precautions    All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
 Disclaimer    While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Table BarTOPTable Bar
Products associated with NOG recombinant proteinPathways associated with NOG recombinant protein
 Reference Product  PubMed Publications
 BMP4 recombinant protein  >17 publications with NOG and BMP4
 GDF5 recombinant protein  >10 publications with NOG and GDF5
 BMP2 recombinant protein  >9 publications with NOG and BMP2
 BMPR1A recombinant protein  >8 publications with NOG and BMPR1A
 BMPR1B recombinant protein  >4 publications with NOG and BMPR1B
 BMPR2 recombinant protein  >3 publications with NOG and BMPR2
 BMP7 recombinant protein  >3 publications with NOG and BMP7
 BMP6 recombinant protein  >2 publications with NOG and BMP6
 Products by Pathway  Pathway Diagram
 BMP Receptor Signaling Pathway antibodies  BMP Receptor Signaling Pathway Diagram
 BMP Signalling And Regulation Pathway antibodies  BMP Signalling And Regulation Pathway Diagram
 Cardiac Progenitor Differentiation Pathway antibodies  Cardiac Progenitor Differentiation Pathway Diagram
 Signal Transduction Pathway antibodies  Signal Transduction Pathway Diagram
 Signaling By BMP Pathway antibodies  Signaling By BMP Pathway Diagram
 TGF Beta Signaling Pathway antibodies  TGF Beta Signaling Pathway Diagram
 TGF-beta Signaling Pathway antibodies  TGF-beta Signaling Pathway Diagram
 TGF-beta Signaling Pathway antibodies  TGF-beta Signaling Pathway Diagram
Diseases associated with NOG recombinant proteinOrgans/Tissues associated with NOG recombinant protein
 Disease Name  Pubmed Publications
 Disease Models, Animal Antibodies  >49 publications with NOG and Disease Models, Animal
 Nervous System Diseases Antibodies  >30 publications with NOG and Nervous System Diseases
 Neoplasms, Experimental Antibodies  >21 publications with NOG and Neoplasms, Experimental
 Inflammation Antibodies  >11 publications with NOG and Inflammation
 Neoplasm Metastasis Antibodies  >10 publications with NOG and Neoplasm Metastasis
 Liver Neoplasms Antibodies  >10 publications with NOG and Liver Neoplasms
 Liver Diseases Antibodies  >9 publications with NOG and Liver Diseases
 Cardiovascular Diseases Antibodies  >9 publications with NOG and Cardiovascular Diseases
 Breast Neoplasms Antibodies  >8 publications with NOG and Breast Neoplasms
 Liver Neoplasms, Experimental Antibodies  >6 publications with NOG and Liver Neoplasms, Experimental
 Organ/Tissue Name  Pubmed Publications
 Blood Antibodies  >102 publications with NOG and Blood
 Spleen Antibodies  >20 publications with NOG and Spleen
 Brain Antibodies  >14 publications with NOG and Brain
 Uterus Antibodies  >8 publications with NOG and Uterus
 Prostate Antibodies  >3 publications with NOG and Prostate
 Placenta Antibodies  >1 publications with NOG and Placenta
Table BarTOPTable Bar
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions